Logix Biosciences, Inc

Overview

Logix Biosciences develops a patented class of structurally disruptive antimicrobials, engineered to defeat resistant bacteria, act as an effective antiviral, and drive angiogenic tissue repair.

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. Pharmaceutical Preparation Manufacturing325412